Cargando…
In vitro activity of ceftazidime-avibactam against Gram-negative strains in patients with complicated urinary tract infection and complicated intra-abdominal infection in Colombia 2014-2018
Ceftazidime/avibactam (CAZ/AVI) has excellent in vitro activity against enterobacterales and Pseudomonas aeruginosa. The study aimed to analyze the in vitro antimicrobial activity of CAZ/AVI and other antibiotics against isolates of enterobacterales and P. aeruginosa from patients with complicated u...
Autores principales: | Lemos-Luengas, Elkin V., Rentería-Valoyes, Sixta, Cárdenas-Isaza, Paola, Ramos-Castaneda, Jorge A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387470/ https://www.ncbi.nlm.nih.gov/pubmed/35618040 http://dx.doi.org/10.1016/j.bjid.2022.102369 |
Ejemplares similares
-
2782. In vitro activity of ceftazidime-avibactam against Gram-negative strains in patients with bacteremia and skin and soft-tissue infections in Colombia 2019-2021
por: Lemos-Luengas, Elkin, et al.
Publicado: (2023) -
Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
por: Goodlet, Kellie J, et al.
Publicado: (2016) -
Ceftazidime–Avibactam versus Meropenem for the Treatment of Complicated Intra-Abdominal Infections
por: Tan, Che-Kim, et al.
Publicado: (2019) -
Ceftazidime/avibactam for specified infections
Publicado: (2020) -
Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam
por: Bassetti, Matteo, et al.
Publicado: (2020)